Related references
Note: Only part of the references are listed.The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation
Khadija Alawi et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Group II metabotropic glutamate receptor activation on peripheral nociceptors modulates TRPV1 function
Susan M. Carlton et al.
BRAIN RESEARCH (2009)
Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway
Martin J. Gunthorpe et al.
DRUG DISCOVERY TODAY (2009)
TRP channels as emerging targets for pain therapeutics
Lisa M. Broad et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Capsaicin-Induced Glutamate Release Is Implicated in Nociceptive Processing Through Activation of Ionotropic Glutamate Receptors and Group I Metabotropic Glutamate Receptor in Primary Afferent Fibers
You-Hong Jin et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia
Prisca Honore et al.
PAIN (2009)
TRPV1 antagonists: the challenges for therapeutic targeting
Neelima Khairatkar-Joshi et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Arpad Szallasi et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Recent Progress in the Development of Selective TRPV1 Antagonists for Pain
Lisa M. Broad et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists
Laxmikant A. Gharat et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2008)
Sensitization of Primary Afferent Nociceptors Induced by Intradermal Capsaicin Involves the Peripheral Release of Calcitonin Gene-Related Peptide Driven by Dorsal Root Reflexes
Dingge Li et al.
JOURNAL OF PAIN (2008)
Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats
Sonya G. Lehto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
Narender R. Gavva et al.
PAIN (2008)
The emerging role of TRPV1 in diabetes and obesity
Anish Suri et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans
Boris A. Chizh et al.
PAIN (2007)
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
Narender R. Gavva et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
From chills to chilis: mechanisms for thermosensation and chemesthesis via thermoTRPs
Michael Bandell et al.
CURRENT OPINION IN NEUROBIOLOGY (2007)
Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors
Alexandre A. Steiner et al.
JOURNAL OF NEUROSCIENCE (2007)
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Arpad Szallasi et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation
Narender R. Gavva et al.
JOURNAL OF NEUROSCIENCE (2007)
Reduced anxiety, conditioned fear, and hippocampal long-term Potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice
Rudolph Marsch et al.
JOURNAL OF NEUROSCIENCE (2007)
Transient receptor potential ion channels as participants in thermosensation and thermoregulation
Michael J. Caterina
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain
Weiya Ma et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Biochemistry and pharmacology of endovanilloids
Katarzyna Starowicz et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1
Thomas Christoph et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists
M. Cui et al.
JOURNAL OF NEUROSCIENCE (2006)
TRPV1 antagonists: a survey of the patent literature
Donald J. Kyle et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development
HK Rami et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: Therapeutic implications
ET Tzavara et al.
BIOLOGICAL PSYCHIATRY (2006)
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain
L. Cristino et al.
NEUROSCIENCE (2006)
Advances in the development of TRPV1 antagonists
Craig C. Correll et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
TRP channels: a TR(I)P through a world of multifunctional cation channels
B Nilius et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2005)
Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission
HB Wang et al.
JOURNAL OF NEUROSCIENCE (2005)
A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats
P Honore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Heat hyperalgesia after incision requires TRPV1 and is distinct from pure inflammatory pain
EM Pogatzki-Zahn et al.
PAIN (2005)
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain
A Tóth et al.
MOLECULAR BRAIN RESEARCH (2005)
AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties
NR Gavva et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain
JR Ghilardi et al.
JOURNAL OF NEUROSCIENCE (2005)
Capsaicin infused into the PAG affects rat tail flick responses to noxious heat and alters neuronal firing in the RVM
S McGaraughty et al.
JOURNAL OF NEUROPHYSIOLOGY (2003)
N-(4-tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl) tetrahydropyrazine-1(2H)-carbox-amide(BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties:: II.: In vivo characterization in rat models of inflammatory and neuropathic pain
JD Pomonis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
JB Davis et al.
NATURE (2000)
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
MJ Caterina et al.
SCIENCE (2000)
Share Paper
